rs11669534

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003283.6(TNNT1):​c.47-13C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.156 in 1,499,846 control chromosomes in the GnomAD database, including 20,718 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1416 hom., cov: 31)
Exomes 𝑓: 0.16 ( 19302 hom. )

Consequence

TNNT1
NM_003283.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: -0.0470

Publications

5 publications found
Variant links:
Genes affected
TNNT1 (HGNC:11948): (troponin T1, slow skeletal type) This gene encodes a protein that is a subunit of troponin, which is a regulatory complex located on the thin filament of the sarcomere. This complex regulates striated muscle contraction in response to fluctuations in intracellular calcium concentration. This complex is composed of three subunits: troponin C, which binds calcium, troponin T, which binds tropomyosin, and troponin I, which is an inhibitory subunit. This protein is the slow skeletal troponin T subunit. Mutations in this gene cause nemaline myopathy type 5, also known as Amish nemaline myopathy, a neuromuscular disorder characterized by muscle weakness and rod-shaped, or nemaline, inclusions in skeletal muscle fibers which affects infants, resulting in death due to respiratory insufficiency, usually in the second year. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNNT1 Gene-Disease associations (from GenCC):
  • nemaline myopathy 5
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • nemaline myopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • nemaline myopathy 5C, autosomal dominant
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 19-55146720-G-A is Benign according to our data. Variant chr19-55146720-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 31863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.176 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNNT1NM_003283.6 linkc.47-13C>T intron_variant Intron 3 of 13 ENST00000588981.6 NP_003274.3 P13805-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNNT1ENST00000588981.6 linkc.47-13C>T intron_variant Intron 3 of 13 1 NM_003283.6 ENSP00000467176.1 P13805-1

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
17915
AN:
151942
Hom.:
1414
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0324
Gnomad AMI
AF:
0.124
Gnomad AMR
AF:
0.119
Gnomad ASJ
AF:
0.135
Gnomad EAS
AF:
0.00291
Gnomad SAS
AF:
0.0503
Gnomad FIN
AF:
0.146
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.179
Gnomad OTH
AF:
0.103
GnomAD2 exomes
AF:
0.105
AC:
12796
AN:
121404
AF XY:
0.106
show subpopulations
Gnomad AFR exome
AF:
0.0208
Gnomad AMR exome
AF:
0.102
Gnomad ASJ exome
AF:
0.144
Gnomad EAS exome
AF:
0.000491
Gnomad FIN exome
AF:
0.131
Gnomad NFE exome
AF:
0.150
Gnomad OTH exome
AF:
0.126
GnomAD4 exome
AF:
0.161
AC:
216723
AN:
1347786
Hom.:
19302
Cov.:
32
AF XY:
0.158
AC XY:
104449
AN XY:
659544
show subpopulations
African (AFR)
AF:
0.0250
AC:
767
AN:
30668
American (AMR)
AF:
0.105
AC:
2990
AN:
28592
Ashkenazi Jewish (ASJ)
AF:
0.146
AC:
3025
AN:
20652
East Asian (EAS)
AF:
0.000560
AC:
21
AN:
37478
South Asian (SAS)
AF:
0.0572
AC:
3960
AN:
69208
European-Finnish (FIN)
AF:
0.136
AC:
6288
AN:
46070
Middle Eastern (MID)
AF:
0.0874
AC:
449
AN:
5136
European-Non Finnish (NFE)
AF:
0.182
AC:
191443
AN:
1054310
Other (OTH)
AF:
0.140
AC:
7780
AN:
55672
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
7981
15962
23944
31925
39906
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6830
13660
20490
27320
34150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.118
AC:
17918
AN:
152060
Hom.:
1416
Cov.:
31
AF XY:
0.114
AC XY:
8497
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0324
AC:
1344
AN:
41532
American (AMR)
AF:
0.119
AC:
1817
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.135
AC:
466
AN:
3462
East Asian (EAS)
AF:
0.00291
AC:
15
AN:
5150
South Asian (SAS)
AF:
0.0508
AC:
245
AN:
4824
European-Finnish (FIN)
AF:
0.146
AC:
1546
AN:
10602
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.179
AC:
12129
AN:
67888
Other (OTH)
AF:
0.102
AC:
216
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
762
1524
2285
3047
3809
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0897
Hom.:
191
Bravo
AF:
0.114
Asia WGS
AF:
0.0390
AC:
135
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jan 09, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 26, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.47-13C>T in intron 3 of TNNT1: This variant is not expected to have clinical s ignificance because it has been identified in 14% (985/6886) of European America n chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.ed u/EVS/; dbSNP rs11669534). -

Nemaline myopathy 5 Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 24, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 18, 2012
Leiden Muscular Dystrophy (TNNT1)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
12
DANN
Benign
0.93
PhyloP100
-0.047
PromoterAI
0.0052
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11669534; hg19: chr19-55658088; API